Liraglutide, a GLP-1 receptor agonist, has also been tested in milk sEV-liraglutide oral liquid formulations, but it failed to lower blood glucose levels in mouse models, consistent with our own finding that liquid formulations are ineffective for oral delivery 30
The most prominent theory is that dimerization causes the development of a particular tissue-building receptor
This review examines the link between diabetes and neurodegenerative diseases, explores the effects of antidiabetic agents on neurodegeneration, provides a concise overview of the GLP-1 pathway, and discusses both preclinical and clinical trial outcomes of GLP-1RAs for neurodegenerative diseases, including their effects on cognition in AD and PD
In general, the above described studies show that supplementation with Bacopa monnieri , acacia gum, acai seed extract, wolfberry preparation, milk fat globule and trigonelline was able to mitigate the ES-induced alterations in behavior